Professor Anu Wartiovaara | |
---|---|
Born | Anu Elina Suomalainen 1966 (age 57–58) [1] |
Alma mater | University of Helsinki |
Scientific career | |
Institutions | University of Helsinki |
Thesis | Mutations of mitochondrial DNA in human disease (1993) |
Anu Wartiovaara ( née Suomalainen; born 1966) is a Finnish neuroscience and biomedical researcher, holding the Sigrid Jusélius Professorship of clinical molecular medicine at the University of Helsinki, specialising in mitochondrial disorders. [2]
She has also been appointed as an Academy Professor of the Research Council of Finland since 2017. [2]
In 2007, Wartiovaara was elected as a member of the Finnish Academy of Science and Letters. [3]
In 2013, she was elected as member of the European Molecular Biology Organization EMBO. [4]
In 2021, the Finnish Medical Society Duodecim awarded Wartiovaara the Matti Äyräpää Prize for her work on mitochondrial diseases. [5]
In 2022, she was elected Member of the Academia Europaea. [6]
She gained an MD and PhD from the University of Helsinki, with postdoctoral research at the National Public Health Institute of Finland and McGill University of Canada. [7]
Some of Wartiovaara's publications have appeared under her maiden name Suomalainen, or Suomalainen-Wartiovaara. [2]
Professor Anu Wartiovaara | |
---|---|
Born | Anu Elina Suomalainen 1966 (age 57–58) [1] |
Alma mater | University of Helsinki |
Scientific career | |
Institutions | University of Helsinki |
Thesis | Mutations of mitochondrial DNA in human disease (1993) |
Anu Wartiovaara ( née Suomalainen; born 1966) is a Finnish neuroscience and biomedical researcher, holding the Sigrid Jusélius Professorship of clinical molecular medicine at the University of Helsinki, specialising in mitochondrial disorders. [2]
She has also been appointed as an Academy Professor of the Research Council of Finland since 2017. [2]
In 2007, Wartiovaara was elected as a member of the Finnish Academy of Science and Letters. [3]
In 2013, she was elected as member of the European Molecular Biology Organization EMBO. [4]
In 2021, the Finnish Medical Society Duodecim awarded Wartiovaara the Matti Äyräpää Prize for her work on mitochondrial diseases. [5]
In 2022, she was elected Member of the Academia Europaea. [6]
She gained an MD and PhD from the University of Helsinki, with postdoctoral research at the National Public Health Institute of Finland and McGill University of Canada. [7]
Some of Wartiovaara's publications have appeared under her maiden name Suomalainen, or Suomalainen-Wartiovaara. [2]